GL1X · GenesisL1 explorer

Research workbench

Crystal structure of TM1643

Analyse Crystal structure of TM1643 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1H2H
Type
protein
Length
233 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hypothetical protein TM1643
UniProt
Q9X1X6
Ligands
NAD
Pockets
2 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHypothetical protein TM1643protein23337% helix, 25% strandQ9X1X6

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12270.540.7739NAD
21430.390.7221empty

Modifications

Observed in the structure: 4 modified (engineered).

Compared structures

  • 1H2H · Crystal structure of TM1643 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9X1X6 · AlphaFold monomer V2.0 prediction for L-aspartate dehydrogenase (Q9X1X6) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.